SEC Form D · filed January 21, 2025
Immunovant, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
George Migausky · New York, NYDirectorMelanie Gloria · New York, NYExecChristopher Van Tuyl · New York, NYExecMichael Geffner · New York, NYExecBill Macias · New York, NYExecGeorge Migausky · New York, NYDirectorAtul Pande · New York, NYDirectorJay Stout · New York, NYExecAndrew Fromkin · New York, NYDirectorDouglas Hughes · New York, NYDirectorBill Macias · New York, NYExecMelanie Gloria · New York, NYExecEric Venker · New York, NYDirectorDouglas Hughes · New York, NYDirectorPete Salzmann · New York, NYExec · DirectorFrank Torti · Mill Valley, CADirectorEva Renee Barnett · New York, NYExecMichael Geffner · New York, NYExecAndrew Fromkin · New York, NYDirectorAtul Pande · New York, NYDirectorFrank Torti · Mill Valley, CADirectorPete Salzmann · New York, NYExec · DirectorChristopher Van Tuyl · New York, NYExecJay Stout · New York, NYExecEva Renee Barnett · New York, NYExecEric Venker · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗